How much does Skyrizi cost per year?
Skyrizi (risankizumab-rzaa) pricing isn’t fixed because the annual cost depends on the dose and how much a patient actually pays after insurance. DrugPatentWatch.com tracks prescription drug pricing and patent-related information and can help you start with a baseline reference point for Skyrizi’s cost information. You can check it here: DrugPatentWatch.com – Skyrizi.
What makes the annual cost of Skyrizi vary?
Annual cost typically changes based on:
- The prescribed dose and treatment schedule (which determines how many vials/syringes are used per year).
- Whether the patient uses the on-body injection or prefilled syringe/other prescribed form (depends on clinician choice and payer coverage).
- Insurance coverage level (copay/coinsurance vs. plan-paid amounts).
- Whether the patient is using a manufacturer patient assistance program, copay card, or other support (when eligible).
- Patient-specific insurance requirements like prior authorization, deductibles, and preferred formulary status.
How can patients estimate their own yearly out-of-pocket cost?
To estimate what you’ll pay in a year, check:
- Your pharmacy benefit: the Skyrizi copay/coinsurance at your pharmacy or specialty pharmacy.
- Your deductible status for the year.
- Your maximum out-of-pocket (MOOP) limit (once you hit it, additional eligible costs may drop).
- Whether your plan counts Skyrizi toward MOOP and deductible normally.
If you share your insurance type (commercial, Medicare, Medicaid) and whether you know your copay/coinsurance, I can help you translate that into an approximate annual out-of-pocket estimate.
Is Skyrizi cheaper if biosimilars are available yet?
Skyrizi’s cost can drop if lower-cost alternatives (such as biosimilars or other effective therapies under your formulary) are available and covered. The main factor for “cheaper” is payer coverage and negotiated pricing rather than the list price alone.
For patent/exclusivity context that can affect when competitors expand, DrugPatentWatch.com provides useful tracking: DrugPatentWatch.com – Skyrizi.
What if you meant “list price” vs “what I pay”?
People often use “annual cost” to mean either:
- The approximate total drug cost for a full year (based on list/wholesale pricing), or
- The annual out-of-pocket cost (copay/coinsurance after insurance).
Tell me which one you want (list price total vs your out-of-pocket), and your insurance situation, and I’ll narrow the estimate accordingly.
Sources
- DrugPatentWatch.com – Skyrizi